Perpetual Ltd

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1647273 SYDNEY, NEW SOUTH WALES, C3

Position in REGN

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$1,500,860

-$156,452 QoQ

Shares Held

2,407

+12.2% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#573

of 1,322 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Perpetual Ltd holds $110,919,281 across 11 Biotechnology names. REGN ranks #5 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARQT	Arcutis Biotherapeutics, Inc.	1,109,657	$29,095,206
2	ARGX	Argenx SE	28,246	$26,205,790
3	GMAB	Genmab A/S	919,048	$25,246,248
4	JAZZ	Jazz Pharmaceuticals plc	104,264	$25,124,495
5	REGN	Regeneron Pharmaceuticals, Inc. This page	2,407	$1,500,860
6	VRTX	Vertex Pharmaceuticals Inc / Ma	1,897	$942,296
7	ALNY	Alnylam Pharmaceuticals, Inc.	2,722	$819,403
8	BBIO	BridgeBio Pharma, Inc.	8,583	$639,261

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,500,860	2,407	+12.2%	Shares	Defined	2026-07-15
2026-03-31	$1,657,312	2,145	0.0%	Shares	Defined	2026-04-14
2025-12-31	$1,655,661	2,145	-96.9%	Shares	Defined	2026-01-20
2024-09-30	$73,277,734	69,706	-5.2%	Shares	Defined	2024-10-09
2024-06-30	$77,276,980	73,525	-13.3%	Shares	Defined	2024-07-30
2024-03-31	$81,598,939	84,779	-15.4%	Shares	Defined	2024-04-16
2023-12-31	$88,021,345	100,219	-5.9%	Shares	Defined	2024-02-15
2023-09-30	$87,689,679	106,554	-6.9%	Shares	Defined	2023-10-10
2023-06-30	$82,227,561	114,437	-5.9%	Shares	Defined	2023-07-13
2023-03-31	$99,966,836	121,663	+1943.7%	Shares	Sole	2023-05-08
2020-09-30	$3,332,370	5,953	-13.2%	Shares	Sole	2020-12-08
2020-06-30	$4,277,615	6,859	+4.8%	Shares	Sole	2020-12-08
2020-03-31	$3,196,346	6,546	—	Shares	Sole	2020-12-08
No filing history on record for this holder in this stock.